Australia, Dec. 23 -- MUSECELL INNOVATIONS Pte. Ltd., owns the trademark (2591867) for 'Dezawa Muse Cell' till July 25, 2035.
Status: protected:
Registered/protected
Classes: 3 [Anti-aging cosmetic preparations; anti-aging cream; anti-aging creams; anti-aging creams for cosmetic purposes; anti-aging creams for sun protection for the face and body; anti-aging masks for cosmetic purposes; anti-aging moisturisers; anti-aging moisturizers; anti-aging serums for cosmetic purposes; anti-aging serums for cosmetic use; anti-aging serums for sensitive skin; anti-aging skincare preparations; anti-aging sun protection creams for the face and body.], 5 [Cells for medical purposes; cells for medical use; cellular function activating agents for medical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; cellulose for pharmaceutical purposes; chemicals for cell separation and cultivation for medical or veterinary purposes; chemicals for separating and cultivating cells for medical or veterinary purposes; living cells for medical purposes; living cells for medical use; pharmaceutical compositions containing stem cells for the treatment of diseases; pharmaceutical preparations containing stem cells; pharmaceutical preparations for activating cellular function; stem cells for medical purposes; autoinjectors prefilled with pharmaceutical preparations; immunological products for intravenous injections; injectable medicinal solutions; injectable solutions for medical purposes; injectable solutions for use in inhibiting peristalsis for medical purposes; pharmaceutical preparations sold in pre-filled injectors; intravenous fluids used for the delivery of pharmaceutical preparations; intravenous solutions for medical purposes; immunosuppressive pharmaceutical preparations; pharmaceutical preparations for the treatment of cystic fibrosis; glycerophosphates; phosphates for pharmaceutical purposes; cardiovascular agents for medical purposes; cardiovascular pharmaceutical preparations; cardiovascular pharmaceuticals; cardiovascular preparations; cardiovascular treatment preparations; drugs for the treatment of cardiovascular diseases; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations and substances for the prevention of cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention of cardiovascular disorders; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for treating cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; anti-ulcer agents; pharmaceutical preparations being antiulceratives; pharmaceutical preparations for the treatment of chronic liver diseases.], 42 [Analysis of stem cells for medical research; cell culture services for scientific and research purposes, for others; culturing of cells for scientific research purposes; research and development in the field of microorganisms and cells; research and development services in the field of microorganisms and cells; research in the field of cell engineering technology; research of induced pluripotent stem cells; scientific services relating to the isolation and cultivation of human tissues and cells; stem cell research; stem cell research services.] and 44 [Human cell bank services; medical services relating to the removal, treatment and processing of stem cells; stem cell bank services; stem cell therapy services; medical services relating to the removal, treatment and processing of human cells; storage of human cells; storage of stem cells [stem cell bank services]; providing on-line information relating to the prevention of cardiovascular disease and strokes; medical services relating to the removal, treatment and processing of bone marrow; medical services relating to the removal, treatment and processing of umbilical cord blood; providing information relating to the treatment of cardiovascular and cerebrovascular diseases via the internet; health care services for treating Alzheimer's disease.]
Type of Mark: Word
Date of Acceptance: Oct. 14
Registration Advertised: Dec. 22
For further details contact MUSECELL INNOVATIONS Pte. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2591867.
Disclaimer: Curated by HT Syndication.
